Neil Chatterji
Stock Analyst at B. Riley Securities
(0.68)
# 3,750
Out of 4,732 analysts
17
Total ratings
26.67%
Success rate
-10.63%
Average return
Main Sectors:
Stocks Rated by Neil Chatterji
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
OPRX OptimizeRx | Maintains: Buy | $17 → $13 | $4.81 | +170.55% | 3 | Dec 24, 2024 | |
ESTA Establishment Labs Holdings | Maintains: Buy | $95 → $50 | $34.56 | +44.68% | 2 | Nov 9, 2023 | |
ARAY Accuray | Reiterates: Buy | $7.5 | $2.24 | +234.82% | 1 | Oct 4, 2023 | |
ZUMZ Zumiez | Maintains: Neutral | $15 → $18 | $15.47 | +16.35% | 2 | Sep 8, 2023 | |
KRMD KORU Medical Systems | Initiates: Buy | $4.5 | $4.09 | +10.02% | 1 | Sep 7, 2023 | |
HYPR Hyperfine | Maintains: Buy | $2.5 → $3.5 | $0.98 | +257.51% | 3 | Aug 15, 2023 | |
STXS Stereotaxis | Maintains: Buy | $6 → $5.5 | $2.08 | +164.42% | 2 | Mar 6, 2023 | |
CLPT ClearPoint Neuro | Reinstates: Buy | $14 | $15.04 | -6.91% | 1 | Feb 16, 2023 | |
FNA Paragon 28 | Initiates: Buy | $32 | $10.88 | +194.12% | 1 | Dec 14, 2022 | |
BFLY Butterfly Network | Initiates: Buy | $9.5 | $3.67 | +158.86% | 1 | Oct 4, 2022 |
OptimizeRx
Dec 24, 2024
Maintains: Buy
Price Target: $17 → $13
Current: $4.81
Upside: +170.55%
Establishment Labs Holdings
Nov 9, 2023
Maintains: Buy
Price Target: $95 → $50
Current: $34.56
Upside: +44.68%
Accuray
Oct 4, 2023
Reiterates: Buy
Price Target: $7.5
Current: $2.24
Upside: +234.82%
Zumiez
Sep 8, 2023
Maintains: Neutral
Price Target: $15 → $18
Current: $15.47
Upside: +16.35%
KORU Medical Systems
Sep 7, 2023
Initiates: Buy
Price Target: $4.5
Current: $4.09
Upside: +10.02%
Hyperfine
Aug 15, 2023
Maintains: Buy
Price Target: $2.5 → $3.5
Current: $0.98
Upside: +257.51%
Stereotaxis
Mar 6, 2023
Maintains: Buy
Price Target: $6 → $5.5
Current: $2.08
Upside: +164.42%
ClearPoint Neuro
Feb 16, 2023
Reinstates: Buy
Price Target: $14
Current: $15.04
Upside: -6.91%
Paragon 28
Dec 14, 2022
Initiates: Buy
Price Target: $32
Current: $10.88
Upside: +194.12%
Butterfly Network
Oct 4, 2022
Initiates: Buy
Price Target: $9.5
Current: $3.67
Upside: +158.86%